Pyogenic Granuloma During Ibrutinib Therapy for B-Cell Neoplasia

JCO Oncol Pract. 2020 Dec;16(12):834-836. doi: 10.1200/OP.20.00037. Epub 2020 Aug 17.

Authors

Xavier Roussel¹, Romain Charollais², Eric Deconinck^{1

3}, Etienne Daguindau^{1

3}, Annie Brion¹

Affiliations

¹ Department of Hematology, University Hospital of Besançon, Jean Minjoz Hospital, Besançon, France.
² Department of Dermatology, Hospital of Haute Saone, Vesoul, France.
³ INSERM UMR1098, EFS BFC, University of Bourgogne Franche-Comté, Besançon, France.

PMID: 32804585
DOI: 10.1200/OP.20.00037

No abstract available

MeSH terms

Adenine / analogs & derivatives
B-Lymphocytes
Granuloma, Pyogenic*
Humans
Neoplasms*
Piperidines
Pyrazoles / adverse effects

Substances

Piperidines
Pyrazoles
ibrutinib
Adenine